Anticoagulação na síndrome coronária aguda / Anticoagulation in acute coronary syndrome
Rev. Soc. Cardiol. Estado de Säo Paulo
;
24(3): 31-39, jul.-set.2014.
Article
in Portuguese
| LILACS
| ID: lil-763795
RESUMO
As síndromes coronárias agudas geralmente resultam da instabilização de uma placa aterosclerótica, com subsequente ativação plaquetária e de diversos fatores de coagulação.O tratamento visa aliviar a dor isquêmica, limitar o dano miocárdico e diminuir a mortalidade. Diversos agentes anticoagulantes provaram sua utilidade e novas drogas passarama compor o arsenal terapêutico atual, buscando maior eficácia anti-isquêmica e menores índices de sangramento. Apesar dos avanços, as taxas de mortalidade, reinfarto e reinternação ainda permanecem elevadas. Nessa revisão, sintetizamos as características e aplicabilidade dos anticoagulantes aprovados para o tratamento das síndromes coronárias agudas.
ABSTRACT
Acute coronary syndromes usually are the result of thedestabilization of atherosclerotic plaque with subsequent plateletand various coagulation factors activation. Treatment aims torelieve ischemic pain, limit myocardial damage and decreasemortality. Several anticoagulants have proven their usefulnessand new drugs compose the therapeutic arsenal, seekinggreater anti-ischemic efficacy and lower rates of bleeding.Despite advances, mortality rates, infarction and hospitalreadmission still remains high. In this review we summarizedthe characteristics and applicability of the anticoagulants thatare approved for the treatment of acute coronary syndromes.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Heparin
/
Enoxaparin
/
Acute Coronary Syndrome
/
Anticoagulants
Limits:
Humans
Language:
Portuguese
Journal:
Rev. Soc. Cardiol. Estado de Säo Paulo
Journal subject:
Cardiology
Year:
2014
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Hospital Israelita Albert Einstein/BR
Similar
MEDLINE
...
LILACS
LIS